Pressurized intraperitoneal aerosol chemotherapy, reasons for interrupting treatment: a systematic review of the literature.

Anne-Cecile EzannoBrice MalgrasMarc Pocard

Published in: Pleura and peritoneum (2023)

Further investigations are necessary to better understand the causes for interrupting PIPAC treatment and also improving the selection of patients who are most likely to benefit from PIPAC.

Keyphrases

end stage renal disease
newly diagnosed
squamous cell carcinoma
locally advanced
smoking cessation
rectal cancer